РусскийEnglish
Russia: +7 (495) 684-4333

Materia Medica Holding


Is a research and manufacturing company, established in 1992, is the major Russian manufacturer of homeopathic products and original patented drugs based on ultra-low doses of antibodies.

News

28.12.2011

Happy New Year and Christmas!


28.11.2011

Materia Medica enters South-East Asia market


31.05.2011

1 June – International Children Day


News archives

To specialists

Ultralow Doses(History of one Research) Epstein O.I.

A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-α and diclofenac in rheumatoid arthritis. Dudina J.L, Petrov V.I., Babayeva A.R., Martyushev-Poklad A.V., Tcherevkova E.V., Epstein O.I., Sergeeva S.A

Sexual incentive motivation in old male rats: The effects of sildenafil and a compound (Impaza) stimulating endothelial NO synthase. Xi Chu a, Anders Agmo

Read more

Products

Anaferon


Anaferon is an original agent for the treatment and prevention of influenza and acute respiratory viral infections. It has been developed on the basis of ultra-low doses of antibodies against interferon-gamma, an endogenous regulator of the immune system.

All Products

Создание сайта «Веб-студия ITSoft»
OOO NPF Materia Medica Holding
www.materiamedica.ru
9 bld, 3rd Samotyochnyi per., Moscow, 127 473, Russia
+7 (495) 684-4333 E-mail: moffice@materiamedica.ru